Added to basket
Unapplied Changes
InMode Ltd—a leading global provider of innovative medical technologies—is proud to introduce Evolve, a non-invasive hands-free workstation designed to remodel skin, treat adipose tissue, and tone muscles.
InMode's leadership in the minimally invasive treatment market continues to be characterised by its reputation as an innovative company that delivers exceptional results to physicians and their patients.
A three dimensional approach
The success of InMode's Subdermal Adipose Remodelling Devices (SARD—Morpheus8, FaceTite and AccuTite) in the minimally invasive space inspired InMode to apply the same principles of facial and body remodelling to the non-invasive market, in a hands-free application. Utilising its unique bipolar technology for delivering radio-frequency energy and electromagnetic pulses, Evolve is the only all-in-one hands-free device for the treatment of skin, subdermal fat and muscle tone improvement.
Evolve is InMode's formal entry into the hands-free market and is founded on a unique three-dimensional approach to tissue remodelling. Its innovative design deploys three proprietary technologies—Tite, Trim, and Tone—allowing for customised treatment for a variety of body types.
A non-invasive solution
Dr Erez Dayan, Plastic and Reconstructive Surgeon, commented, "Today's patients are seeking a customisable and effective solution for their aesthetic goals. This is the first time that I have the ability to offer a non-invasive solution tailored to my patient's needs. The Evolve platform is clinically the most effective solution available for the treatment of skin, fat and muscle. With the great results that are achieved, we see high levels of patient satisfaction."
"Our ability and success in bringing innovative solutions to the market are derived directly from listening carefully to our customers. The demand for an all-inclusive body solution in the non-invasive space is long overdue. We are proud to be the first company to offer the full range of treatments from non-invasive to minimally invasive in this segment. This exciting new technology is the latest addition to the InMode portfolio; as we continue to innovate, this ecosystem will only become more robust," said Shakil Lakhani, President of North America at InMode.
For more information about InMode and our wide array of medical technologies, visit inmodemd.co.uk
